Allison C. Hoffman Sells 1,245 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 1,245 shares of the business's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $26.89, for a total value of $33,478.05. Following the completion of the transaction, the general counsel owned 136,978 shares of the company's stock, valued at $3,683,338.42. This represents a 0.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.

Phreesia Trading Up 4.0%

Shares of PHR traded up $1.03 during mid-day trading on Monday, reaching $26.51. 597,110 shares of the company's stock traded hands, compared to its average volume of 456,444. The stock's 50-day moving average is $26.50 and its two-hundred day moving average is $26.41. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.95 and a quick ratio of 1.95. The stock has a market cap of $1.58 billion, a P/E ratio of -35.82 and a beta of 0.72. Phreesia, Inc. has a 12 month low of $17.07 and a 12 month high of $30.53.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, beating analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business had revenue of $115.94 million during the quarter, compared to analyst estimates of $115.00 million. During the same quarter last year, the business posted ($0.05) EPS. The company's revenue was up 14.5% on a year-over-year basis. Research analysts forecast that Phreesia, Inc. will post -1.1 earnings per share for the current fiscal year.

Institutional Trading of Phreesia

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Johnson Financial Group Inc. lifted its holdings in shares of Phreesia by 381.3% in the 4th quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after purchasing an additional 896 shares during the last quarter. Quarry LP lifted its stake in Phreesia by 210.9% in the fourth quarter. Quarry LP now owns 2,835 shares of the company's stock valued at $71,000 after buying an additional 1,923 shares during the last quarter. KBC Group NV acquired a new stake in shares of Phreesia in the first quarter valued at approximately $74,000. Farther Finance Advisors LLC grew its position in shares of Phreesia by 9,375.0% during the second quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company's stock worth $86,000 after acquiring an additional 3,000 shares during the last quarter. Finally, CWM LLC increased its holdings in shares of Phreesia by 994.9% in the 1st quarter. CWM LLC now owns 4,040 shares of the company's stock valued at $103,000 after acquiring an additional 3,671 shares during the period. Hedge funds and other institutional investors own 92.10% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on PHR shares. KeyCorp increased their price target on Phreesia from $28.00 to $35.00 and gave the company an "overweight" rating in a research note on Monday, July 14th. DA Davidson decreased their target price on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a research report on Monday, April 14th. Citigroup reaffirmed a "buy" rating on shares of Phreesia in a research note on Wednesday, May 28th. Truist Financial boosted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a research note on Thursday, May 29th. Finally, Wall Street Zen raised Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia has an average rating of "Buy" and a consensus target price of $32.27.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.